In the present study, we investigated the effects of short-term administration of a high-dose of atorvastatin on the conventional breast cancer pathological markers ER, PR, HER2, as well as the cell cycle regulators cyclin D1 and p27. This evidence concerns the gene PGR and breast carcinoma.